• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button Iconrare diseases

rare diseases

CommentaryMy son’s rare disease diagnosis spurred me to ditch Big Pharma for a biotech startup
By Michelle WernerMarch 10, 2025
HealthCéline Dion says she may never tour again amid battle with stiff person syndrome. Here’s what to know
By Alexa Mikhail and Jordyn BradleyApril 23, 2024
Health‘Desperate for answers’: Thousands of people finally received diagnoses that had eluded them for years. Here’s how
By Erin PraterApril 14, 2023
HealthIt takes an average of 8 years for a rare disease patient to get diagnosed. Why is it so hard to get life-altering genetic testing in the U.S.?
By Erin PraterFebruary 28, 2023
Mother holds child's hand
HealthParents are becoming drug developers to find a cure for their children’s rare diseases
By Jared Whitlock and Kaiser Health NewsJuly 21, 2022
Girl (8-9) smiling behind a pink protective face mask
HealthLong COVID in kids is worrying the experts: ‘It affects everybody differently and at different timescales’
By David MeyerOctober 20, 2021
CommentaryCures for many rare diseases might already exist. Why aren’t we using them?
By Annette BakkerJuly 5, 2021
COVID forgotten communities
NewslettersThe communities we forget during COVID-19
By Sy MukherjeeApril 30, 2020
HealthThe coronavirus pandemic is impacting critical research into neuromuscular diseases
By Sy MukherjeeApril 28, 2020
HealthAn FDA Program Incentivizing Rare Disease Drugs Will Be Investigated for Abuses
By Sy MukherjeeMarch 22, 2017
HealthMartin Shkreli’s Former Company, Back in Business, Vows No Crazy Drug Prices
By Sy MukherjeeJuly 1, 2016
Shire Plc's U.K. Offices As Drugmaker Rejects Abbvie Inc.'s $46.5 Billion Offer
Shire switches from target to predator with $5.2 billion NPS buy
By Geoffrey SmithJanuary 12, 2015
1
  • 1
1
Most Popular
Magazine
The youngest-ever female CEO of a Fortune 500 company is fighting Trump's cuts to keep Medicaid strongAn image of a popular article
By Fortune EditorsMarch 24, 2026
Commentary
The Treasury just declared the U.S. insolvent. The media missed itAn image of a popular article
By Fortune EditorsMarch 23, 2026
Success
Palantir’s billionaire CEO says only two kinds of people will succeed in the AI era: trade workers — ‘or you’re neurodivergent’An image of a popular article
By Fortune EditorsMarch 24, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.